NIH-funded research R01 grant

Understanding how HLA-C affects chronic inflammation in pregnancy

Official title: The role of HLA-C in chronic chorioamnionitis

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11027190 · Data updated 2026-11-12

This study is looking at how a specific protein called HLA-C affects the immune cells in pregnant women with chronic chorioamnionitis, a condition that causes inflammation in the placenta, to help find better ways to treat it and improve pregnancy health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startJanuary 1, 2025
Project endNovember 30, 2029
Funding year2025
Award (this year)$630,107
NIH project number1R01HD116852-01
Project IDNIH-11027190 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pregnant individuals experiencing chronic chorioamnionitis or related complications.

Less likely to help

Patients who are not pregnant or those without any signs of chronic chorioamnionitis may not benefit from this research.

What this research studies

This research investigates the role of Human Leukocyte Antigen-C (HLA-C) in chronic chorioamnionitis (CCA), a condition characterized by inflammation of the placental membranes. The study aims to clarify how HLA-C influences the activity of maternal CD8 T cells, which can contribute to tissue damage during pregnancy. By examining the interactions between HLA-C and these immune cells, the research seeks to uncover the underlying mechanisms that lead to excessive cell death in the placenta. This could ultimately inform new treatment strategies for managing CCA and improving pregnancy outcomes.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for chronic chorioamnionitis, potentially reducing risks associated with pregnancy complications.

How similar studies have gone: Previous research has shown promising results in understanding immune responses in pregnancy, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Tilburgs, Tamara — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Tilburgs, Tamara

Related research

Other NIH-funded projects on the same topics.

  • Accelerating Rheumatic Heart Disease Prevention in Uganda

    A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11645314

  • Enhanced surveillance network to track childhood vaccines and viral infections in kids

    A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11624109

  • Advancing CNS drug delivery through epigenetic tweaks

    A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11617801

  • Spina Bifida Registry for Better Clinic Care

    A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11616587

  • Hydroxyurea to help children with sickle cell anemia in Africa

    A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606512

  • Hydroxyurea for Children with Sickle Cell in Africa

    A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11606510

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.